Compass is rumored to be in talks to buy BHHS, but the real estate arm of Berkshire Hathaway “has seen better days,” in ...

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today ...

Compass tapped its cash reserves to pay $155 million in cash and $250 million in stock for the Chicago-grown brokerage ...

Compass (COMP) has been making significant strides in the real estate brokerage sector with its technology-driven platform.

Leerink analyst Andrew Berens upgraded Compass Therapeutics (CMPX) to Outperform from Market Perform with a price target of $6, up from $4, ...

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) has been given an average rating of “Buy” by the six ratings firms that ...

A Compass broker reportedly faces allegations of illegally accepting kickbacks from a mortgage lender and attorney in ...

Wedbush reiterated their outperform rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report ...

The final phase—knowing—isn’t about certainty in the traditional sense. It’s about developing an inner compass that guides ...

Northstar Technologies Group has acquired Compass Quantum, an independently operated subsidiary of Compass Datacenters, through an agreement that will drive the next phase of Quantum's growth.